{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T03:19:08Z","timestamp":1782271148831,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T00:00:00Z","timestamp":1484697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T00:00:00Z","timestamp":1484697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1038\/ja.2016.165","type":"journal-article","created":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T07:22:06Z","timestamp":1484724126000},"page":"671-674","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Thiazomycin, nocathiacin and analogs show strong activity against clinical strains of drug-resistant Mycobacterium tuberculosis"],"prefix":"10.1038","volume":"70","author":[{"given":"Sheo B","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T","family":"Meinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Kurepina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry N","family":"Kreiswirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,18]]},"reference":[{"key":"BFja2016165_CR1","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.1002\/anie.200701058","volume":"46","author":"H Jayasuriya","year":"2007","unstructured":"Jayasuriya, H. et al. Isolation and structure of platencin: a novel FabH and FabF Dual inhibitor with potent broad spectrum antibiotic activity produced by Streptomyces platensis MA7339. Angew. Chem. Int. Ed. Engl. 46, 4684\u20134688 (2007).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"BFja2016165_CR2","doi-asserted-by":"publisher","first-page":"8818","DOI":"10.1016\/j.bmc.2008.08.079","volume":"16","author":"C Zhang","year":"2008","unstructured":"Zhang, C. et al. Isolation, structure and antibacterial activity of Thiazomycin A, a potent thiazolyl peptide antibiotic from Amycolatopsis fastidiosa. Bioorg. Med. Chem. 16, 8818\u20138823 (2008).","journal-title":"Bioorg. Med. Chem."},{"key":"BFja2016165_CR3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1021\/np800783b","volume":"72","author":"C Zhang","year":"2009","unstructured":"Zhang, C. et al. Thiazomycins, thiazolyl peptide antibiotics from Amycolatopsis fastidiosa. J. Nat. Prod. 72, 841\u2013847 (2009).","journal-title":"J. Nat. Prod."},{"key":"BFja2016165_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/ja.2013.54","volume":"66","author":"SB Singh","year":"2013","unstructured":"Singh, S. B. et al. Occurrence, distribution, dereplication and efficient discovery of thiazolyl peptides by sensitive-resistant pair screening. J. Antibiot. (Tokyo) 66, 599\u2013607 (2013).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"BFja2016165_CR5","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/ja.2007.71","volume":"60","author":"SB Singh","year":"2007","unstructured":"Singh, S. B. et al. Antibacterial evaluations of thiazomycin- a potent thiazolyl peptide antibiotic from Amycolatopsis fastidiosa. J. Antibiot. (Tokyo) 60, 565\u2013571 (2007).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"BFja2016165_CR6","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1016\/j.bmcl.2009.04.144","volume":"19","author":"L Xu","year":"2009","unstructured":"Xu, L. et al. Nocathiacin analogs: synthesis and antibacterial activity of novel water-soluble amides. Bioorg. Med. Chem. Lett. 19, 3531\u20133535 (2009).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"BFja2016165_CR7","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.bmcl.2012.10.065","volume":"23","author":"L Xu","year":"2013","unstructured":"Xu, L. et al. Synthesis and antibacterial activity of novel water-soluble nocathiacin analogs. Bioorg. Med. Chem. Lett. 23, 366\u2013369 (2013).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"BFja2016165_CR8","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1128\/AAC.48.10.3697-3701.2004","volume":"48","author":"MJ Pucci","year":"2004","unstructured":"Pucci, M. J. et al. Antimicrobial evaluation of nocathiacins, a thiazole peptide class of antibiotics. Antimicrob. Agents Chemother. 48, 3697\u20133701 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2016165_CR9","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S1473-3099(13)70030-6","volume":"13","author":"I Abubakar","year":"2013","unstructured":"Abubakar, I. et al. Drug-resistant tuberculosis: time for visionary political leadership. Lancet Infect. Dis. 13, 529\u2013539 (2013).","journal-title":"Lancet Infect. Dis."},{"key":"BFja2016165_CR10","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/ja.2007.70","volume":"60","author":"H Jayasuriya","year":"2007","unstructured":"Jayasuriya, H. et al. Isolation and structure elucidation of thiazomycin- a potent thiazolyl peptide antibiotic from Amycolatopsis fastidiosa. J. Antibiot. (Tokyo) 60, 554\u2013564 (2007).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"BFja2016165_CR11","unstructured":"Debenham, S. D. et al Antibiotic compounds WO2007127135 (2007)."},{"key":"BFja2016165_CR12","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1021\/cr0300441","volume":"105","author":"MC Bagley","year":"2005","unstructured":"Bagley, M. C., Dale, J. W., Merritt, E. A. & Xiong, X. Thiopeptide antibiotics. Chem. Rev. 105, 685\u2013714 (2005).","journal-title":"Chem. Rev."},{"key":"BFja2016165_CR13","doi-asserted-by":"publisher","first-page":"226","DOI":"10.7164\/antibiotics.56.226","volume":"56","author":"W Li","year":"2003","unstructured":"Li, W. et al. Nocathiacins, new thiazolyl peptide antibiotics from Nocardia sp. I. Taxonomy, fermentation and biological activities. J. Antibiot. (Tokyo) 56, 226\u2013231 (2003).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"BFja2016165_CR14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1086\/376837","volume":"188","author":"SS Munsiff","year":"2003","unstructured":"Munsiff, S.S. et al. Persistence of a highly resistant strain of tuberculosis in New York City during 1990-1999. J. Infect. Dis. 188, 356\u2013363 (2003).","journal-title":"J. Infect. Dis."},{"key":"BFja2016165_CR15","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1128\/JCM.00160-06","volume":"44","author":"M Macaraig","year":"2006","unstructured":"Macaraig, M et al. Strain-specific differences in two large Mycobacterium tuberculosis genotype clusters in isolates collected from homeless patients in New York City from 2001 to 2004. J. Clin. Microbiol. 44, 2890\u20132896 (2006).","journal-title":"J. Clin. Microbiol."},{"key":"BFja2016165_CR16","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/genetics\/162.4.1533","volume":"162","author":"MM Gutacker","year":"2002","unstructured":"Gutacker, M. M. et al. Genome-wide analysis of synonymous single nucleotide polymorphisms in Mycobacterium tuberculosis complex organisms: resolution of genetic relationships among closely related microbial strains. Genetics 162, 1533\u20131543 (2002).","journal-title":"Genetics"},{"key":"BFja2016165_CR17","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1128\/CMR.00061-05","volume":"19","author":"B Mathema","year":"2006","unstructured":"Mathema, B., Kurepina, N. E., Bifani, P. J. & Kreiswirth, B. N. Molecular epidemiology of tuberculosis: current insights. Clin. Microbiol. Rev. 19, 658\u2013685 (2006).","journal-title":"Clin. Microbiol. Rev."}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ja2016165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ja2016165","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ja.2016.165","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/ja2016165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T02:16:16Z","timestamp":1641003376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ja2016165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,18]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["BFja2016165"],"URL":"https:\/\/doi.org\/10.1038\/ja.2016.165","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,18]]},"assertion":[{"value":"22 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The work described in this paper was conducted and supported by Merck & Co., Inc., a for-profit public company dedicated to discovery, development, manufacturing and sale of antibiotics and other drugs. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}